Skip to main content
Clinical Trials/NL-OMON29392
NL-OMON29392
Recruiting
Not Applicable

Rate Control Efficacy in permanent atrial fibrillation, a comparison between lenient verus strict rate control in patients with and without heart failure.

etherlands Heart FoundationInteruniversity Cardioly Institute the NetherlandsAstraZenecaAventis SanofiBiotronikGuidantMedtronicRocheVitatron0 sites500 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Not specified
Sponsor
etherlands Heart FoundationInteruniversity Cardioly Institute the NetherlandsAstraZenecaAventis SanofiBiotronikGuidantMedtronicRocheVitatron
Enrollment
500
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

/A

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
etherlands Heart FoundationInteruniversity Cardioly Institute the NetherlandsAstraZenecaAventis SanofiBiotronikGuidantMedtronicRocheVitatron

Eligibility Criteria

Inclusion Criteria

  • 1\. Patients with persistent AF \< 12 months;
  • 2\. Age \< 80 years;
  • 3\. Resting heart rate \> 80 beats per minute;
  • 4\. On oral anticoagulation.

Exclusion Criteria

  • 1\. Paroxysmal AF;
  • 2\. Known contraindications for strict or lenient rate control;
  • 3\. Unstable heart failure;
  • 4\. Cardiac surgery.
  • 5\. Any current stroke;
  • 6\. Foreseen pacemaker or cardiac resynchronization therapy;
  • 7\. Sick sinus syndrome or AV node conduction disturbances;
  • 8\. Untreated hyperthyroidism;
  • 9\. Inability to walk or bike.

Outcomes

Primary Outcomes

Not specified

Similar Trials